The Hidden Cost of Evergreening: How Patent Strategies Are Stalling Innovation and Keeping Prices High
Imagine a world where groundbreaking medicines reach patients faster, innovation flourishes, and healthcare costs become more manageable. Now, contra…

In the high-stakes world of pharmaceutical innovation, the race to extend market exclusivity isn’t just about groundbreaking science—it’s a strategic chess game played behind closed doors. Recent insights from Drug Patent Watch reveal a sophisticated t…

In the relentless race to bring groundbreaking medicines to market, pharmaceutical companies are often ensnared in a complex web of patent thickets—interwoven layers of intellectual property rights that can delay innovation, inflate costs, and stifle c…

In the fiercely competitive world of pharmaceuticals, gaining even a fleeting edge can translate into billions in revenue. Yet, many companies overlook a critical strategic asset embedded within the patent system: the 180-day exclusivity period awarded…

In the fiercely competitive world of pharmaceutical innovation, securing a patent challenge victory can be a game-changer—yet, the path to success is riddled with pitfalls. For biotech firms and pharma giants alike, navigating the complex landscape of …

In the high-stakes world of biopharmaceuticals, understanding where value truly lies can be the difference between lucrative investment and missed opportunity. As the industry evolves, so does the complexity of its value chain—yet many investors remain…

In the high-stakes world of pharmaceutical innovation, China’s evolving patent landscape is akin to navigating a treacherous dragon’s den—full of opportunity, but fraught with peril for the unprepared. As global pharma giants and biotech startups alike…

In the high-stakes world of pharmaceutical market access, timing isn’t just everything—it’s the difference between securing a competitive edge and falling behind. Yet, one of the most overlooked yet critical components of strategic planning remains the…

In the high-stakes world of pharmaceuticals, innovation is often viewed as the lifeblood of growth. But lurking beneath this narrative is a strategic, sometimes controversial practice known as “evergreening”—a tactic that can extend patent protections,…

In the complex world of pharmaceuticals, few markets are as challenging—and as potentially rewarding—as rare disease therapeutics. Yet, despite the promise, many generic companies hesitate to enter these niche spaces, caught in a paradox that can stall…